Unique Activation of Matrix Metalloproteinase-9 Within Human Liver Metastasis from Colorectal Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1998 Aug 14

PMID 9703281

Citations 8

Authors

Z S Zeng

J G Guillem

Affiliations

Soon will be listed here.

Abstract

Experimental in vitro and animal data support an important role for matrix metalloproteinases (MMPs) in cancer invasion and metastasis via proteolytic degradation of the extracellular matrix (ECM). Our previous data have shown that MMP-9 mRNA is localized to the interface between liver metastasis and normal liver tissue, indicating that MMP-9 may play an important role in liver metastasis formation. In the present study, we analysed the cellular enzymatic expression of MMP-9 in 18 human colorectal cancer (CRC) liver metastasis specimens by enzyme-linked immunosorbent assay (ELISA) and zymography. ELISA analysis reveals that the latent form of MMP-9 is present in both liver metastasis and paired adjacent normal liver tissue. The mean level of the latent form of MMP-9 is 580+/-270 ng per mg total tissue protein (mean+/-s.e.) in liver metastasis vs 220+/-90 in normal liver tissue. However, this difference is not significantly different (P = 0.26). Using gelatin zymography, the 92-kDa band representative of the latent form is present in both liver metastasis and normal liver tissue. However, the 82 kDa band, representative of the active form of MMP-9, was seen only in liver metastasis. This was confirmed by Western blot analysis. Our observation of the unique presence of the active form of MMP-9 within liver metastasis suggests that proMMP-9 activation may be a pivotal event during CRC liver metastasis formation.

Citing Articles

Calibrating models of cancer invasion: parameter estimation using approximate Bayesian computation and gradient matching.

Xiao Y, Thomas L, Chaplain M R Soc Open Sci. 2021; 8(6):202237.

PMID: 34150312 PMC: 8206694. DOI: 10.1098/rsos.202237.

Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.

van Huizen N, Coebergh van den Braak R, Doukas M, Dekker L, IJzermans J, Luider T J Biol Chem. 2018; 294(1):281-289.

PMID: 30409905 PMC: 6322866. DOI: 10.1074/jbc.RA118.005087.

Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change.

Roh S, Choi E, Cho D, Jang S, Kim S, Kim Y J Korean Med Sci. 2010; 25(3):353-60.

PMID: 20191032 PMC: 2826746. DOI: 10.3346/jkms.2010.25.3.353.

Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Lee A, Chick J, Kolarich D, Haynes P, Robertson G, Tsoli M Mol Cell Proteomics. 2010; 10(9):M900538MCP200.

PMID: 20167946 PMC: 3186205. DOI: 10.1074/mcp.M900538-MCP200.

Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression.

Artinyan A, Essani R, Lake J, Kaiser A, Vukasin P, Danenberg P J Gastrointest Surg. 2005; 9(9):1216-21.

PMID: 16332476 DOI: 10.1016/j.gassur.2005.06.028.

References

Martin M, Chauffert B, Caignard A, Pelletier H, Hammann A, Martin F . Histoimmunological characterization of the cellular reaction to liver metastases induced by colon cancer cells in syngeneic rats. Invasion Metastasis. 1989; 9(4):216-30. View

Rao J, Steck P, Mohanam S, Stetler-Stevenson W, Liotta L, Sawaya R . Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 1993; 53(10 Suppl):2208-11. View

Bottazzi B, Erba E, Nobili N, Fazioli F, Rambaldi A, Mantovani A . A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J Immunol. 1990; 144(6):2409-12. View

Rajabi M, Dean D, Woessner Jr J . Changes in active and latent collagenase in human placenta around the time of parturition. Am J Obstet Gynecol. 1990; 163(2):499-505. DOI: 10.1016/0002-9378(90)91183-d. View

Welgus H, Campbell E, Cury J, Eisen A, Senior R, Wilhelm S . Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest. 1990; 86(5):1496-502. PMC: 296895. DOI: 10.1172/JCI114867. View

Nakajima M, Morikawa K, Fabra A, Bucana C, Fidler I . Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst. 1990; 82(24):1890-8. DOI: 10.1093/jnci/82.24.1890. View

Lyons J, Moore W, OGrady R, Birkedal-Hansen H . Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry. 1991; 30(6):1449-56. DOI: 10.1021/bi00220a001. View

Walter S, Govoni D, Bottazzi B, Mantovani A . The role of macrophages in the regulation of primary tumor growth. Pathobiology. 1991; 59(4):239-42. DOI: 10.1159/000163654. View

Liotta L, Stetler-Stevenson W . Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991; 51(18 Suppl):5054s-5059s. View

10.

Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K . Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 1992; 52(5):1336-41. View

11.

Ogata Y, Enghild J, Nagase H . Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem. 1992; 267(6):3581-4. View

12.

Matrisian L . The matrix-degrading metalloproteinases. Bioessays. 1992; 14(7):455-63. DOI: 10.1002/bies.950140705. View

13.

Stearns M, Wang M . Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res. 1993; 53(4):878-83. View

14.

Pyke C, Ralfkiaer E, Tryggvason K, Dano K . Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 1993; 142(2):359-65. PMC: 1886712. View

15.

Zeng Z, Huang Y, Cohen A, Guillem J . Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol. 1996; 14(12):3133-40. DOI: 10.1200/JCO.1996.14.12.3133. View

16.

Parker S, Tong T, Bolden S, Wingo P . Cancer statistics, 1997. CA Cancer J Clin. 1997; 47(1):5-27. DOI: 10.3322/canjclin.47.1.5. View

17.

Davies B, Miles D, Happerfield L, Naylor M, Bobrow L, Rubens R . Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer. 1993; 67(5):1126-31. PMC: 1968428. DOI: 10.1038/bjc.1993.207. View

18.

Heuff G, van der Ende M, Boutkan H, Prevoo W, Bayon L, Fleuren G . Macrophage populations in different stages of induced hepatic metastases in rats: an immunohistochemical analysis. Scand J Immunol. 1993; 38(1):10-6. DOI: 10.1111/j.1365-3083.1993.tb01688.x. View

19.

Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T . Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993; 53(22):5365-9. View

20.

Hamdy F, Fadlon E, Cottam D, Lawry J, Thurrell W, Silcocks P . Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer. 1994; 69(1):177-82. PMC: 1968786. DOI: 10.1038/bjc.1994.30. View